BlackRock’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $10.7M | Sell |
|
|||||
|
2023
Q4 | $9.97M | Buy |
|
|||||
|
2023
Q3 | $8.52M | Buy |
|
|||||
|
2023
Q2 | $8.32M | Buy |
|
|||||
|
2023
Q1 | $2.73M | Buy |
|
|||||
|
2022
Q4 | $2.4M | Buy |
|
|||||
|
2022
Q3 | $775K | Sell |
|
|||||
|
2022
Q2 | $1.24M | Sell |
|
|||||
|
2022
Q1 | $1.34M | Sell |
|
|||||
|
2021
Q4 | $832K | Buy |
|
|||||
|
2021
Q3 | $1.02M | Buy |
|
|||||
|
2021
Q2 | $1.2M | Sell |
|
|||||
|
2021
Q1 | $1.6M | Buy |
|
|||||
|
2020
Q4 | $1.74M | Sell |
|
|||||
|
2020
Q3 | $1.01M | Buy |
|
|||||
|
2020
Q2 | $836K | Buy |
|
|||||
|
2020
Q1 | $533K | Sell |
|
|||||
|
2019
Q4 | $783K | Sell |
|
|||||
|
2019
Q3 | $1.12M | Sell |
|
|||||
|
2019
Q2 | $1.51M | Sell |
|
|||||
|
2019
Q1 | $1.77M | Sell |
|
|||||
|
2018
Q4 | $989K | Buy |
|
|||||
|
2018
Q3 | $1.35M | Buy |
|
|||||
|
2018
Q2 | $1.24M | Sell |
|
|||||
|
2018
Q1 | $6.48M | Sell |
|
|||||
|
2017
Q4 | $8.33M | Sell |
|
|||||
|
2017
Q3 | $15M | Buy |
|
|||||
|
2017
Q2 | $12.6M | Sell |
|
|||||
|
2017
Q1 | $35.6M | Buy |
|
|||||
|
2016
Q4 | $71K | Sell |
|
|||||
|
2016
Q3 | $221K | Buy |
|
|||||
|
2016
Q2 | $151K | Buy |
|
|||||
|
2016
Q1 | $66K | Buy |
|
|||||
|
2015
Q4 | $27K | Buy |
|
|||||
|
2015
Q3 | $28K | Buy |
|
|||||
|
2015
Q2 | $35K | Buy |
|
|||||
|
2015
Q1 | $33K | Sell |
|
|||||
|
2014
Q4 | $38K | Hold |
|
|||||
|
2014
Q3 | $29K | Hold |
|
|||||
|
2014
Q2 | $25K | Sell |
|
|||||
|
2014
Q1 | $19K | Hold |
|
|||||
|
2013
Q4 | $21K | Hold |
|
|||||
|
2013
Q3 | $14K | Buy |
|
|||||
|
2013
Q2 | $23K | Buy |
|